Cat. #160692
Anti-CEACAM1-dN [3-9F-3G]
Cat. #: 160692
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: recombinant CEACAM1-dN-Fc (mAb does not bind the N domain)
Class: Monoclonal
Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: LeukoCom
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-CEACAM1-dN [3-9F-3G]
- Research fields: Cancer;Cell biology
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 100 kDa
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
- Description: Epithelia, endothelia and leukocyte expression and sera of macaque; potential tumor marker
- Immunogen: recombinant human CEACAM1-Fc protein
- Immunogen uniprot id: P13688
- Myeloma used: NS1/0
- Recommended controls: IgG1 kappa
Target Details
- Target: recombinant CEACAM1-dN-Fc (mAb does not bind the N domain)
- Molecular weight: 100 kDa
- Tissue cell line specificity: IgG1 kappa
- Target background: Epithelia, endothelia and leukocyte expression and sera of macaque; potential tumor marker
Applications
- Application: ELISA ; FACS ; IHC ; IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
